{
    "Trade/Device Name(s)": [
        "EasyStat 300"
    ],
    "Submitter Information": "Medica Corporation",
    "510(k) Number": "K220396",
    "Predicate Device Reference 510(k) Number(s)": [
        "K963694"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "JFP",
        "CGZ",
        "CEM"
    ],
    "Summary Letter Date": "September 26, 2023",
    "Summary Letter Received Date": "December 2, 2022",
    "Submission Date": "December 1, 2022",
    "Regulation Number(s)": [
        "21 CFR 862.1145",
        "21 CFR 862.1600",
        "21 CFR 862.1170"
    ],
    "Regulation Name(s)": [
        "Calcium Test System",
        "Potassium Test System",
        "Chloride Test System"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Potassium",
        "Ionized Calcium",
        "Chloride"
    ],
    "Specimen Type(s)": [
        "Whole Blood"
    ],
    "Specimen Container(s)": [
        "Li-Heparinized Syringe"
    ],
    "Instrument(s)/Platform(s)": [
        "EasyStat 300"
    ],
    "Method(s)/Technology(ies)": [
        "Ion Selective Electrode (ISE)",
        "Potentiometric measurement"
    ],
    "Methodologies": [
        "Ion selective electrode potentiometry"
    ],
    "Submission Type(s)": [
        "Analyzer",
        "System",
        "Reagent",
        "Quality control material",
        "Cleaning solution",
        "Troubleshooting kit",
        "Barcode scanner"
    ],
    "Document Summary": "FDA 510(k) summary for Medica EasyStat 300 system for quantitative measurement of potassium, ionized calcium, and chloride in whole blood using ion selective electrodes.",
    "Indications for Use Summary": "Quantitative measurement of potassium, ionized calcium, and chloride in arterial/venous whole blood from Li-Heparinized syringes to aid in diagnosis and treatment of patients with electrolyte and/or acid-base disturbances in a clinical laboratory setting.",
    "fda_folder": "Clinical Chemistry"
}